Docs and sources: OpenAI closed a $300M+ share sale at a $27B-$29B valuation; backers include Tiger Global, Sequoia, a16z, Thrive, K2 Global, and Founders Fund
Context & Ripple Effects
This closed sale is the earliest marker in what became a two-and-a-half-year repricing of OpenAI entirely in private markets: by September the company was pitching investors on a sale valuing it near $80-90B, almost triple this level, and by February 2024 it had completed an $80B-plus deal with a Thrive-led tender letting employees cash out.
The buyer list matters as much as the price. Tiger Global, Sequoia, a16z, Thrive, K2 Global, and Founders Fund all took positions at $27B-$29B — and Thrive in particular parlayed this entry into repeated roles in OpenAI's later secondaries, culminating in the [[a:890862|~$6.6B employee sale at a $500B valuation that made OpenAI the world's most valuable startup]], ahead of SpaceX.
First-order effects
- Six named funds — Tiger Global, Sequoia, a16z, Thrive, K2 Global, and Founders Fund — now hold OpenAI equity bought at $27B-$29B, giving existing shareholders and staff their first large-scale liquidity window since ChatGPT turned the cap table into a contested asset.
- Sequoia's participation lands shortly after it closed $10 billion in new funding with Alfred Lin and Pat Grady stepping in as stewards (and Doug Leone returning as chairman), so this is an early flagship deployment for the firm's next fund generation.
Second-order effects
- Thrive converts this early position into a franchise: it returns to lead OpenAI's 2024 tender and reappears in the 2025 ~$500B secondary alongside SoftBank, making repeat access to OpenAI stock a differentiator in fundraising against peers who sat out this round.
- Once insiders can sell at these marks, every later round gets priced off a secondary rather than a primary raise — the September $80-90B pitch and the eventual $500B sale were both structured as share purchases, not new capital into the company itself.
Third-order effects
- If the pattern holds, frontier labs compound valuation through successive employee secondaries instead of an IPO, concentrating ownership of the sector's most valuable asset among a handful of crossover funds — the capital-concentration dynamic the rest of the AI market now prices around.
- A $500B private mark ahead of SpaceX implies late-stage AI equity has effectively become its own liquid asset class, with tender offers doing the job public listings once did for both founder wealth and investor exits.
The trend: Frontier-lab value is being marked up almost entirely through private share sales and tender offers, with a small set of repeat buyers — Thrive chief among them — controlling access to the equity as OpenAI climbs from $27B toward $500B without ever going public.